You are here: Home News Defect in non-coding DNA might trigger brain disorders such as severe language impairment

Defect in non-coding DNA might trigger brain disorders such as severe language impairment

Genetic variation in the non-coding DNA could give rise to language impairments in children and other neurodevelopmental disorders including schizophrenia, autism, and bipolar disorder, scientists from the Max Planck Institute for Psycholinguistics and Radboud University in Nijmegen found. Molecular Psychiatry publishes their work based on a new approach on March 14.
Defect in non-coding DNA might trigger brain disorders such as severe language impairment

The human genome is made up of ~3 billion letters of DNA and at each position, it is possible to have different letters, called variants. Some variants are harmless but others can be detrimental, making it a mammoth task to find out which variants cause a disorder. Researchers often choose to search only the 1-2% of the genome that carries the information to make proteins. While this has been successful for a few disorders, most neurodevelopmental disorders are still largely unexplained, making it clear that looking elsewhere in the genome is necessary.

“The remaining 98% of the genome offers a lot of untapped potential to find changes that can cause disorders” Paolo Devanna, co-author of the study explains. “These parts of the genome are known as ‘non-coding’, but that doesn’t mean that they are not important. They have very vital jobs to do, for example, to control when, where and how much protein is made. So if this process gets messed up, it could have severe consequences, like neurodevelopmental disorders.” For this reason, Devanna and his colleagues decided to look at the so-called 3’UTRome. This is a part of the non-coding genome that regulates how much protein is made.

Searching for causes of language impairment

To test this approach, the researchers looked at the DNA of children with severe language problems and identified genetic variants in the 3’UTRome. “Language disorders are a very complex neurodevelopmental disorder and finding their genetic causes has been particularly challenging – we have only a small number of candidate genes thus far,” said Dr Sonja Vernes who led the study. She runs a research group at the Max Planck Institute for Psycholinguistics and is part of the Donders Institute for Brain, Cognition and Behaviour at the Radboud University, both in Nijmegen, the Netherlands.

The researchers tested the impact of each 3’UTRome variant on the expression of the candidate genes for languages impairment. One of the variants has a significant effect on the expression of a gene known as ARHGEF39. “If a cell carries this single letter change in the 3’UTRome, they express more ARHGEF39. We were very excited by this finding because this is the first time we have found a variant associated with specific language impairment that we can show has a clear biological effect” said Devanna. “Having too much of a protein at important points in development could affect how neurons and neuronal circuits develop and function, which could, in turn, could affect how children develop their language skills” Vernes explains.

The researchers were able to find the specific gene variants, which seem to contribute to language impairment, through collaboration with the UK Specific Language Impairment Consortium. 

Non-coding variants are widespread in genetic disorders

Given this success, the researchers went on to explore the 3’UTRome in other neurodevelopmental disorders. They identified 25 further genetic changes in the DNA of individuals with autism, schizophrenia and bipolar disorder that are thought to control protein levels in the same way. "We are tapping into a new and promising source of genetic variation," Vernes said. "Our study shows that the identification and testing of non-coding variants will foster our understanding of the genetic causes of neurodevelopmental disorders, which is crucial in the long term for the design of new and effective therapeutics.”

Neurodevelopmental disorders (NDDs) like schizophrenia, autism and bipolar disorders encompass a wide range of disabilities associated with the functioning of the brain. Severe NDDs are currently known to affect approximately 5% of the population, making understanding their causes and in turn, their possible treatments an important area of study.

More information and contact

-          Sonja Vernes Sonja.Vernes@mpi.nl               +31 24 3521941

-          Paolo Devanna Paolo.Devanna@mpi.nl           +31 24 3521939

Publication

Devanna, P.,  Chen, X.S., Ho, J., Gajewski, D.,  Smith, S.D., Gialluisi, A., Francks, C., Fisher, S.E., Newbury, D.F., & Vernes, S.C. (2017). Next-gen sequencing identifies non-coding variation disrupting miRNA binding sites in neurological disorders. Molecular Psychiatry. DOI: 10.1038/MP.2017.30

About MPI

This is the MPI

The Max Planck Institute for Psycholinguistics is an institute of the German Max Planck Society. Our mission is to undertake basic research into the psychological,social and biological foundations of language. The goal is to understand how our minds and brains process language, how language interacts with other aspects of mind, and how we can learn languages of quite different types.

The institute is situated on the campus of the Radboud University. We participate in the Donders Institute for Brain, Cognition and Behaviour, and have particularly close ties to that institute's Centre for Cognitive Neuroimaging. We also participate in the Centre for Language Studies. A joint graduate school, the IMPRS in Language Sciences, links the Donders Institute, the CLS and the MPI.

 

Max Planck Institute
for Psycholinguistics

 

Street address
Wundtlaan 1
6525 XD Nijmegen
The Netherlands


Mailing address
P.O. Box 310
6500 AH Nijmegen
The Netherlands

Phone:   +31-24-3521911
Fax:        +31-24-3521213
E-mail:   


Public Outreach Officer
Charlotte Horn

Image right

scrabble